EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,248,000 | -50.0% | 18,000 | -45.5% | 0.08% | -62.9% |
| Q2 2018 | $2,497,000 | +43.6% | 33,000 | 0.0% | 0.21% | +23.8% |
| Q1 2018 | $1,739,000 | -1.4% | 33,000 | 0.0% | 0.17% | -6.5% |
| Q4 2017 | $1,763,000 | -63.8% | 33,000 | -59.5% | 0.18% | -63.9% |
| Q3 2017 | $4,864,000 | -53.3% | 81,550 | -38.2% | 0.51% | -58.7% |
| Q2 2017 | $10,413,000 | +85.4% | 131,990 | +95.0% | 1.23% | +64.6% |
| Q1 2017 | $5,615,000 | +73.9% | 67,700 | +66.3% | 0.75% | +13.2% |
| Q4 2016 | $3,229,000 | +59.1% | 40,700 | +40.3% | 0.66% | +80.1% |
| Q3 2016 | $2,030,000 | – | 29,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |